ARTICLE | Company News
Navidea, Rheumco deal
August 11, 2014 7:00 AM UTC
Navidea and Rheumco formed a JV to develop and commercialize radiolabeled diagnostics and therapeutics for rheumatologic and arthritic diseases using Navidea’s Manocept CD206 macrophage targeting pla...